The Valley Desk

NCT02927067 · Interventional trial

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Overall registry status Completed

Phase 3

Conditions Cytomegalovirus (CMV)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov